Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward

Author:

Bryant Juliet E.1ORCID,Azman Andrew S.23ORCID,Ferrari Matthew J.4ORCID,Arnold Benjamin F.5ORCID,Boni Maciej F.4,Boum Yap6ORCID,Hayford Kyla2ORCID,Luquero Francisco J.7ORCID,Mina Michael J.8,Rodriguez-Barraquer Isabel9ORCID,Wu Joseph T.10ORCID,Wade Djibril11ORCID,Vernet Guy12,Leung Daniel T.13ORCID

Affiliation:

1. Laboratory of Emerging Pathogens, Fondation Mérieux, Lyon, France.

2. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

3. Médecins Sans Frontières, Geneva, Switzerland.

4. Department Biology and Center for Infectious Disease Dynamics, Pennsylvania State University, University Park, PA, USA.

5. Francis I Proctor Foundation, University of California San Francisco, San Francisco, CA, USA.

6. Epicentre, Yaounde, Cameroon.

7. Epicentre, Paris, France.

8. Departments of Epidemiology and Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA, USA.

9. School of Medicine, University of California San Francisco, San Francisco, CA, USA.

10. WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China.

11. Institut de Recherche en Santé, de Surveillance Épidémiologique et de Formation (IRESSEF), Dakar, Senegal.

12. Institut Pasteur de Bangui, Bangui, Central African Republic.

13. Division of Infectious Diseases, University of Utah School of Medicine, Salt Lake City, UT, USA.

Abstract

Defining acceptable performance characteristics for SARS-CoV-2 serological tests requires factoring in how the results will be used.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine,Immunology

Reference10 articles.

1. The role of antibody testing for SARS-CoV-2: Is there one?;Theel E. S.;J. Clin. Microbiol.,2020

2. Antibody testing will enhance the power and accuracy of COVID-19-prevention trials

3. Dengue pre-vaccination screening and positive predictive values

4. Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications;Wu F.;medRxiv,2020

5. Viral kinetics and antibody responses in patients with COVID-19;Tan W.;medRxiv,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3